158 related articles for article (PubMed ID: 30550588)
21. Perceived discrimination and injecting risk among people who inject drugs attending Needle and Syringe Programmes in Sydney, Australia.
Wilson H; Brener L; Mao L; Treloar C
Drug Alcohol Depend; 2014 Nov; 144():274-8. PubMed ID: 25236889
[TBL] [Abstract][Full Text] [Related]
22. "We get by with a little help from our friends": Small-scale informal and large-scale formal peer distribution networks of sterile injecting equipment in Australia.
Newland J; Newman C; Treloar C
Int J Drug Policy; 2016 Aug; 34():65-71. PubMed ID: 27449331
[TBL] [Abstract][Full Text] [Related]
23. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of high-risk drug use and coverage of opioid substitution treatment and needle and syringe programs in Lithuania in 2015-2016: A multi-method estimation study.
Thanki D; Mravčík V; Běláčková V; Mačiulytė D; Zábranský T; Širvinskienė A; Subata E; Lorenzo-Ortega R
J Subst Abuse Treat; 2021 Mar; 122():108229. PubMed ID: 33509418
[TBL] [Abstract][Full Text] [Related]
25. Global coverage of interventions to prevent and manage drug-related harms among people who inject drugs: a systematic review.
Colledge-Frisby S; Ottaviano S; Webb P; Grebely J; Wheeler A; Cunningham EB; Hajarizadeh B; Leung J; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Degenhardt L
Lancet Glob Health; 2023 May; 11(5):e673-e683. PubMed ID: 36996860
[TBL] [Abstract][Full Text] [Related]
26. Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.
O'Keefe D; Scott N; Aitken C; Dietze P
J Public Health (Oxf); 2018 Sep; 40(3):e336-e342. PubMed ID: 29281039
[TBL] [Abstract][Full Text] [Related]
27. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
[TBL] [Abstract][Full Text] [Related]
28. Factors that influence the characteristics of needles and syringes used by people who inject drugs in Tajikistan.
Zule WA; Latypov A; Otiashvili D; Kirtadze I; Ibragimov U; Bobashev GV
Harm Reduct J; 2015 Oct; 12():37. PubMed ID: 26472669
[TBL] [Abstract][Full Text] [Related]
29. Ability to access community-based needle-syringe programs and injecting behaviors among drug users: a cross-sectional study in Hunan Province, China.
Zhang L; Chen X; Zheng J; Zhao J; Jing J; Zhang J; Chow EP; Wilson DP
Harm Reduct J; 2013 May; 10():8. PubMed ID: 23651665
[TBL] [Abstract][Full Text] [Related]
30. Measuring individual-level needle and syringe coverage among people who inject drugs in Myanmar.
O'Keefe D; Aung SM; Pasricha N; Wun T; Linn SK; Lin N; Aitken C; Hughes C; Dietze P
Int J Drug Policy; 2018 Aug; 58():22-30. PubMed ID: 29754104
[TBL] [Abstract][Full Text] [Related]
31. How does the use of multiple needles/syringes per injecting episode impact on the measurement of individual level needle and syringe program coverage?
O'Keefe D; McCormack A; Cogger S; Aitken C; Burns L; Bruno R; Stafford J; Butler K; Breen C; Dietze P
Int J Drug Policy; 2017 Aug; 46():99-106. PubMed ID: 28667880
[TBL] [Abstract][Full Text] [Related]
32. Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.
Aceijas C; Hickman M; Donoghoe MC; Burrows D; Stuikyte R
Addiction; 2007 Aug; 102(8):1244-50. PubMed ID: 17565564
[TBL] [Abstract][Full Text] [Related]
33. Estimating the cost-effectiveness of needle-syringe programs in Australia.
Kwon JA; Anderson J; Kerr CC; Thein HH; Zhang L; Iversen J; Dore GJ; Kaldor JM; Law MG; Maher L; Wilson DP
AIDS; 2012 Nov; 26(17):2201-10. PubMed ID: 22914579
[TBL] [Abstract][Full Text] [Related]
34. Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation.
Killion JA; Magana C; Cepeda JA; Vo A; Hernandez M; Cyr CL; Heskett KM; Wilson DP; Graff Zivin J; Zúñiga ML; Pines HA; Garfein RS; Vickerman P; Terris-Prestholt F; Wynn A; Martin NK
AIDS; 2023 Dec; 37(15):2389-2397. PubMed ID: 37773035
[TBL] [Abstract][Full Text] [Related]
35. Assessing Syringe Exchange Program Access among Persons Who Inject Drugs (PWID) in the District of Columbia.
Allen ST; Ruiz MS; Jones J
J Urban Health; 2016 Feb; 93(1):131-40. PubMed ID: 26786782
[TBL] [Abstract][Full Text] [Related]
36. Uptake into a bedside needle and syringe program for acute care inpatients who inject drugs.
Brooks HL; O'Brien DC; Salvalaggio G; Dong K; Hyshka E
Drug Alcohol Rev; 2019 May; 38(4):423-427. PubMed ID: 31021491
[TBL] [Abstract][Full Text] [Related]
37. Staff perceptions of syringe dispensing machines in Australia: a pilot study.
Islam MM; Conigrave KM; Stern T
Subst Use Misuse; 2009; 44(4):490-501. PubMed ID: 19283622
[TBL] [Abstract][Full Text] [Related]
38. Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs.
Islam MM; Topp L; Iversen J; Day C; Conigrave KM; Maher L
Aust N Z J Public Health; 2013 Apr; 37(2):148-54. PubMed ID: 23551473
[TBL] [Abstract][Full Text] [Related]
39. Beyond equipment distribution in Needle and Syringe Programmes: an exploratory analysis of blood-borne virus risk and other measures of client need.
Treloar C; Mao L; Wilson H
Harm Reduct J; 2016 May; 13(1):18. PubMed ID: 27246345
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
